Dr. Cobleigh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1725 W Harrison St
Suite 1010
Chicago, IL 60612Phone+1 312-942-5904- Is this information wrong?
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1979 - 1981
- Rush University Medical CenterResidency, Internal Medicine, 1977 - 1979
- Rush University Medical CenterResidency, Internal Medicine, 1976 - 1976
- Rush Medical College of Rush University Medical CenterClass of 1975
Certifications & Licensure
- IL State Medical License 1977 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2017
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer Start of enrollment: 1995 Oct 01
- Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer Start of enrollment: 2000 Nov 28
- Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Start of enrollment: 2002 Jan 29
- Join now to see all
Publications & Presentations
PubMed
- Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.Wei, C., Banach, K., Chu, J., Tung, L., Atallah, I., Cobleigh, M., Rao, R., Feinstein, S., Usha, L., Reiser, J., Okwuosa, T.> ;Cardio-Oncology. 2024 Feb 6
- 1 citationsSoluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study.Wei, C., Banach, K., Chu, J., Tung, L., Cobleigh, M., Rao, R., Feinstein, S., Usha, L., Reiser, J., Okwuosa, T., Atallah, I.> ;Cardio-Oncology. 2024 Jan 15
- Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers.Layng, K., Mauer, E., Mahon, B., Hockenberry, A., Abukhdeir, A., Cobleigh, M.> ;Breast Cancer Research and Treatment. 2023 Dec 28
- Join now to see all
Journal Articles
- Can Chimerism Explain breast/ovarian Cancers in BRCA Non-Carriers from BRCA-Positive Families?Lydia Usha, Melody Cobleigh, PLoS One
Press Mentions
- Dr. Janet Wolter, Oncologist and Cancer Researcher at Rush, DiesFebruary 9th, 2020
Hospital Affiliations
- Rush University Medical CenterChicago, Illinois
- Rush Oak Park HospitalOak Park, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: